EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
Conditions
- Advanced Solid Tumors
- MSI-H or dMMR Advanced Solid Tumors
- MSI-H/dMMR Gastric Cancer
- MSI-H/dMMR Colorectal Cancer
- MSI-H/dMMR Gastroesophageal-junction Cancer
- Endometrial Cancer
- Mismatch Repair Deficient or MSI-High Solid Tumors
Interventions
- DRUG: EIK1005
- DRUG: pembrolizumab (KEYTRUDA® )
Sponsor
Eikon Therapeutics
Collaborators